Related Experiment Video
Updated: Jul 5, 2026
08:32
Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways
Haim Werner1, Doron Weinstein, Itay Bentov
1Department of Human Molecular Genetics and Biochemistry, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. hwerner@post.tau.ac.il
Archives of Physiology and Biochemistry
|May 10, 2008
Summary
Insulin and insulin-like growth factors (IGF-I, IGF-II) regulate metabolism and development. This review compares their structures, receptors, and signaling pathways, highlighting complex cross-talk.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Signaling
Background:
- Insulin and IGFs are crucial hormones with diverse roles in metabolism and development.
- Initially, insulin was linked to metabolic functions, while IGFs were associated with growth and differentiation.
- Emerging evidence reveals significant cross-talk between insulin and IGF family members and their receptors.
Purpose of the Study:
- To provide a comparative analysis of insulin and IGF-I.
- To examine the structures, receptors, and signaling pathways of insulin and IGF-I.
- To elucidate the complex interactions within the insulin and IGF signaling network.
Main Methods:
- Comparative analysis of literature data.
- Review of structural and functional studies.
- Examination of signaling pathway mechanisms.
Main Results:
- Insulin and IGF-I share structural similarities but exhibit distinct receptor binding profiles.
- Both hormones activate overlapping yet unique intracellular signaling cascades.
- Complex cross-talk exists between insulin and IGF signaling pathways, expanding their functional roles.
Conclusions:
- The distinction between insulin and IGF functions is blurred due to extensive cross-talk.
- Understanding these complex interactions is vital for comprehending metabolic and developmental regulation.
- Further research into insulin and IGF signaling pathways is essential for therapeutic advancements.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...